Nvidia Eyes $2.5 Billion Investment in Thinking Machines Lab 
Adobe Names Anil Chakravarthy CEO as AI Push Accelerates 
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies 
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability 
Volkswagen Approves 50,000 More Job Cuts in Major Restructuring 
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up 
Lynas Rare Earths Shares Rise After Takeover Talks Revealed 
SpaceX Turbine Push Unlikely to Threaten Howmet, Bernstein Says 
Anthropic IPO Marketing Expected to Start in Mid-October 
ByteDance Secures $29.6 Billion Loan to Boost AI Investment 
Tesla Cybercab Rides Launch in Austin as NHTSA Reviews Rollout 
Milei Threatens Falkland Oil Firms With Sanctions 
Thomson Reuters C-Track Cyberattack Hits Courts Across U.S. and Canada 
Deutsche Telekom Shares Rise as Elliott Pushes Against T-Mobile Merger 
CATL Shares Fall as Hungary Plant Faces Safety Halt 
Tesla Cybercab Launch Puts Robotaxi Ambitions in Focus 
Xiaomi Shares Jump on Europe EV Expansion Plan 
Add as a preferred source on Google
GAITHERSBURG, Md., March 01, 2018 -- OpGen, Inc. (NASDAQ:OPGN) announced today that Evan Jones, Chairman and Chief Executive Officer of the Company, will present a corporate overview at the Cowen and Company 38th Annual Health Care Conference on Tuesday, March 13, 2018 at 8:40 a.m. Eastern time. The conference will be held March 12-14, 2018 at The Boston Marriott Copley Place.
To listen to the presentation live, investors may visit the investor relations section of OpGen’s website at www.opgen.com. An archived webcast of the presentation will also be available on OpGen’s website for a period of time.
About OpGen
OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection treatment and prevention. Learn more at www.opgen.com and follow OpGen on Twitter and LinkedIn.
OpGen, Acuitas, and Acuitas Lighthouse are registered trademarks of OpGen, Inc. All other trademarks are properties of their respective owners.
OpGen Contact:
Michael Farmer
Sr. Director, Marketing
240-813-1284
[email protected]
[email protected]
Investor Contacts:
LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
[email protected]
or
Bruce Voss
310-691-7100
[email protected]
